Clinical Trials

    A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer

    Investigator: Jian Guan

    Study Coordinator: Huma Zafar

    Status: Enrolling

    ClinicalTrials.gov Number: NCT07673887

    Phone: 713.441.0528

    Protocol Number: PRO00045829

    Description


    Claudin 18.2 or CLDN18.2 is a protein found on cells in the digestive system. It is also found in some tumors. Researchers are looking at ways to attack CLDN18.2 to help control tumors. ASP2138 is thought to bind to CLDN18.2 and a type of immune cell called a T cell. This "tells" the immune system to attack the tumor. ASP2138 is a potential treatment for people with gastric cancer (also known as stomach cancer) or gastroesophageal junction cancer (GEJ cancer). GEJ is where the tube that carries food (esophagus) joins the stomach